Daclizumab
Daclizumab (Zenapax) is a humanized monoclonal antibody that specifically inhibits the alpha subunit of IL-2R-HA. Daclizumab (Zenapax) can inhibit the binding of IL-2 and IL-2R-HA through specific binding to CD25. Daclizumab (Zenapax) studies multiple sclerosis.
Product Specifications
CAS Number
152923-56-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ARP70738_P050-Biotin 100 µL
KRT79 Antibody - C-terminal region : Biotin (ARP70738_P050-Biotin)
Ask
View Details SIPA836Mu01-01 10 µg
Recombinant Receptor For Advanced Glycation Endproducts (RAGE)
Ask
View Details 
SIPA836Mu01-02 50 µg
Recombinant Receptor For Advanced Glycation Endproducts (RAGE)
Ask
View Details SIPA836Mu01-03 200 µg
Recombinant Receptor For Advanced Glycation Endproducts (RAGE)
Ask
View Details